125 related articles for article (PubMed ID: 6302509)
1. Calcium-channel-blocking agents.
Insel PA; Motulsky HJ
N Engl J Med; 1983 Jun; 308(22):1361-2. PubMed ID: 6302509
[No Abstract] [Full Text] [Related]
2. Calcium antagonists and alpha-receptors.
Timmermans PB; van Meel JC; van Zwieten PA
Eur Heart J; 1983 May; 4 Suppl C():11-7. PubMed ID: 6311552
[No Abstract] [Full Text] [Related]
3. Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.
Motulsky HJ; Snavely MD; Hughes RJ; Insel PA
Circ Res; 1983 Feb; 52(2):226-31. PubMed ID: 6297831
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ channel blockers interact with alpha 2-adrenergic receptors in rabbit ileum.
Homaidan FR; Donowitz M; Wicks J; Cusolito S; el Sabban ME; Weiland GA; Sharp WG
Am J Physiol; 1988 Apr; 254(4 Pt 1):G586-94. PubMed ID: 2833118
[TBL] [Abstract][Full Text] [Related]
5. The relationship of receptor reserve and agonist efficacy to the sensitivity of alpha-adrenoceptor-mediated vasopressor responses to inhibition by calcium channel antagonists.
Ruffolo RR; Nichols AJ
Ann N Y Acad Sci; 1988; 522():361-76. PubMed ID: 2897818
[No Abstract] [Full Text] [Related]
6. Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors.
Thayer SA; Welcome M; Chhabra A; Fairhurst AS
Biochem Pharmacol; 1985 Jan; 34(2):175-80. PubMed ID: 2981533
[TBL] [Abstract][Full Text] [Related]
7. Effect of calcium channel blockers on adrenergic and nonadrenergic vascular responses in man.
Pasanisi F; Elliott HL; Meredith PA; Sumner DJ; Reid JL
J Cardiovasc Pharmacol; 1985; 7(6):1166-70. PubMed ID: 2418305
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of calcium antagonist drugs on vasoconstriction induced by vascular alpha 2-adrenoceptor stimulation.
van Zwieten PA; Timmermans PB; Thoolen MJ; Wilffert B; De Jonge A
Am J Cardiol; 1986 Feb; 57(7):11D-15D. PubMed ID: 2869674
[TBL] [Abstract][Full Text] [Related]
9. [Platelet adrenergic alpha receptors in hypertensive subjects undergoing treatment with calcium antagonists].
Radaelli A; Caporotondi A; Muggia C; Pompei R; Marchesi E
Boll Soc Ital Biol Sper; 1990 Jan; 66(1):9-13. PubMed ID: 2157469
[TBL] [Abstract][Full Text] [Related]
10. Calcium handling in vasoconstriction to stimulation of alpha 1- and alpha 2-adrenoceptors.
Timmermans PB; Chiu AT; Thoolen MJ
Can J Physiol Pharmacol; 1987 Aug; 65(8):1649-57. PubMed ID: 2891423
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction between calcium antagonists and the vasoconstriction induced by the stimulation of postsynaptic alpha 2-adrenoceptors.
van Zwieten PA; van Meel JC; Timmermans PB
Circ Res; 1983 Feb; 52(2 Pt 2):I77-80. PubMed ID: 6299607
[No Abstract] [Full Text] [Related]
12. Receptor subtypes involved in the action of calcium entry blockers.
van Zwieten PA; Timmermans PB
Ann N Y Acad Sci; 1988; 522():351-60. PubMed ID: 2454059
[TBL] [Abstract][Full Text] [Related]
13. Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha 2-adrenoceptor-mediated vasopressor responses.
Van Meel JC; Timmermans PB; Van Zwieten PA
Eur J Pharmacol; 1983 Aug; 92(1-2):27-34. PubMed ID: 6313390
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of calcium entry blockers: interaction with vascular alpha-adrenoceptors.
van Zwieten PA; van Meel JC; Timmermans PB
Hypertension; 1983; 5(4 Pt 2):II8-17. PubMed ID: 6134673
[TBL] [Abstract][Full Text] [Related]
15. The effect of calcium channel blockers on alpha 1- and alpha 2-adrenoceptor-mediated vascular responsiveness in man.
Elliott HL; Pasanisi F; Sumner DJ; Reid JL
J Hypertens Suppl; 1985 Dec; 3(3):S235-7. PubMed ID: 2856817
[TBL] [Abstract][Full Text] [Related]
16. Specific alpha-adrenoceptor-mediated vasoconstriction in human veins and interaction with the calcium entry blockers nifedipine and diltiazem.
Schulte KL; Laber E; Meyer-Sabellek WA; Distler A; Gotzen R
J Hypertens Suppl; 1985 Dec; 3(3):S239-41. PubMed ID: 2856818
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1- and alpha 2-adrenoceptor-mediated pressor responses: are they differentiated by calcium antagonists or by functional antagonism?
Lew MJ; Angus JA
J Cardiovasc Pharmacol; 1985; 7(2):401-8. PubMed ID: 2581097
[TBL] [Abstract][Full Text] [Related]
18. [Interaction between calcium antagonists and vascular postsynaptic alpha-receptors].
van Meel JC; Timmermans PB; van Zwieten PA
J Pharmacol; 1982; 13(3):367-79. PubMed ID: 6290792
[TBL] [Abstract][Full Text] [Related]
19. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison with noncalcium entry blocker vasodilators in absence and presence of phenoxybenzamine pretreatment.
Pedrinelli R; Tarazi RC
J Pharmacol Exp Ther; 1985 Jun; 233(3):636-42. PubMed ID: 2989491
[TBL] [Abstract][Full Text] [Related]
20. Calcium entry blockade and alpha-adrenergic responsiveness in vivo.
Pedrinelli R; Tarazi RC
J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S199-205. PubMed ID: 2414588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
